［1］YIN W,WANG J,JIANG L,et al.Cancer and stem cells［J］.Experimental Biology and Medicine,2021,246(16):1791-1801.
［2］CHEN G,HUANG P,HU C.The role of SIRT2 in cancer: A novel therapeutic target［J］.International Journal of Cancer,2020,147(12):3297-3304.
［3］WU QJ,ZHANG TN,CHEN HH,et al.The sirtuin family in health and disease［J］.Signal Transduction and Targeted Therapy,2022,7(1):402.
［4］吴亚芳,亢崇仰,陈悦华,等.Sirt2抑制剂对大鼠出血性脑损伤的改善作用及其对血脑屏障通透性的影响［J］.中西医结合心脑血管病杂志,2022,20(14):2545-2549.
WU YF,KANG CY,CHEN YH,et al.Improvement effect of Sirt2 inhibitor on hemorrhagic brain injury in rats and its effect on blood-brain barrier permeability［J］.Journal of Integrative Cardiovascular and Cerebrovascular Disease,2022,20(14):2545-2549.
［5］FIORENTINO F,MAUTONE N,MENNA M,et al.Sirtuin modulators:past,present,and future perspectives［J］.Future Medicinal Chemistry,2022,14(12):915-939.
［6］REN HH,HU FQ,WANG D,et al.Sirtuin 2 prevents liver steatosis and metabolic disorders by deacetylation of hepatocyte nuclear factor 4α［J］.Hepatology,2021,74(2):723-740.
［7］LIU S,GAO XF,FAN ZL,et al.SIRT2 affects cell proliferation and apoptosis by suppressing the level of autophagy in renal podocytes［J］.Disease Markers,2022,2022:4586198.
［8］WU BQ,YOU SL,QIAN H,et al.The role of SIRT2 in vascular-related and heart-related diseases:A review［J］.Journal of Cellular and Molecular Medicine,2021,25(14):6470-6478.
［9］ZHU C,DONG X,WANG X,et al.Multiple roles of SIRT2 in regulating physiological and pathological signal transduction［J］.Genetics Research,2022,2022:9282484.
［10］WU M,ZHANG JB,XIONG YW,et al.Promotion of lung cancer metastasis by SIRT2-mediated extracellular protein deacetylation［J］.Advanced Science(Weinheim,Baden-Wurttemberg,Germany),2023,10(3):e2205462.
［11］BORJI M,NOURBAKHSH M,SHAFIEE SM,et al.Down-regulation of SIRT1 expression by miR-23b contributes to lipid accumulation in HepG2 cells［J］.Biochemical Genetics,2019,57(4):507-521.
［12］WAGHELA BN,VAIDYA FU,RANJAN K,et al.AGE-RAGE synergy influences programmed cell death signaling to promote cancer［J］.Molecular and Cellular Biochemistry,2021,476(2):585-598.
［13］WAWRUSZAK A,LUSZCZKI J,CZERWONKA A,et al.Assessment of pharmacological interactions between SIRT2 inhibitor AGK2 and paclitaxel in different molecular subtypes of breast cancer cells［J］.Cells,2022,11(7):1211.
［14］ZHENG M,HU C,WU M,et al.Emerging role of SIRT2 in non-small cell lung cancer［J］.Oncology Letters,2021,22(4):731.
［15］DING T,HAO J.Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling,and promotes cell apoptosis and cell cycle arrest in multiple myeloma［J］.Molecular Medicine Reports,2021,24(5):760.
［16］LEE EJ,LEE MM,PARK SY,et al.Sirt2 positively regulates muscle regeneration after Notexin-induced muscle injury［J］.Experimental and Molecular Pathology,2022,127:104798.
［17］YI F,ZHANG Y,WANG Z,et al.The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis［J］.Science Advances,2021,7(9):eabe5518.
［18］XU D,JIANG X,HE H,et al.SIRT2 functions in aging,autophagy,and apoptosis in post-maturation bovine oocytes［J］.Life Sciences,2019,232:116639.
［19］WILKINSON L,GATHANI T.Understanding breast cancer as a global health concern［J］.The British Journal of Radiology,2022,95(1130):20211033.
［20］TANG S,ZHANG J,ZHANG L,et al.Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis［J］.Hepatology Communications,2023,7(10):e0257.
［21］王若亚,张鸳,张继虹,等.靶向突变p53蛋白的抗肿瘤药物［J］.生物化学与生物物理进展,2024,51(01):33-46.
WANG RY,ZHANG Y,ZHANG JH,et al.Antitumor drugs targeting mutant p53 protein［J］.Advances in Biochemistry and Biophysics,2024,51(01):33-46.
［22］LIN R,YANG Y,WU E,et al.SIRT2 promotes cell proliferation and migration through mediating ERK1/2 activation and lactosylceramide accumulation in prostate cancer［J］.The Prostate,2023,83(1):71-81.
［23］VOGELMANN A,SCHIEDEL M,WOSSNER N,et al.Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration［J］.RSC Chemical Biology,2022,3(4):468-485.
［24］TIAN Y,LIU R,HOU X,et al.SIRT2 promotes the viability,invasion and metastasis of osteosarcoma cells by inhibiting the degradation of snail［J］.Cell Death & Disease,2022,13(11):935.
［25］HENDERSON JM,WEBER C,SANTOVITO D.Beyond self-recycling:Cell-specific role of autophagy in atherosclerosis［J］.Cells,2021,10(3):625.
［26］LIU S,GAO X,FAN Z,et al.SIRT2 affects cell proliferation and apoptosis by suppressing the level of autophagy in renal podocytes［J］.Disease Markers,2022,2022:4586198.
［27］GUO J,NIE J,CHEN Z,et al.Cold exposure-induced endoplasmic reticulum stress regulates autophagy through the SIRT2/FoxO1 signaling pathway［J］.Journal of Cellular Physiology,2022,237(10):3960-3970.
［28］ZANDIEH MA,FARAHANI MH,RAJABI R,et al.Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors:Biological functions and therapeutic perspectives［J］.Pharmacological Research,2023,187:106582.
［29］ZHANG Y,WANG X,LI X,et al.Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice［J］.European Heart Journal,2023,44(29):2746-2759.
［30］HU Z,XU W,YANG X,et al.SIRT2 inhibition attenuates the vasculopathy and vision impairment via Akt signaling in retinopathy of prematurity［J］.Experimental Eye Research,2023,233:109547.
［31］OON CE,SUBRAMANIAM AV,OOI LY,et al.BZD9L1 benzimidazole analogue hampers colorectal tumor progression by impeding angiogenesis［J］.World Journal of Gastrointestinal Oncology,2023,15(5):810-827.
［32］CEBALLOS MP,ANGEL A,DELPRATO CB,et al.Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells［J］.European Journal of Pharmacology,2021,892:173736.
［33］ACKLIN S,SADHUKHAN R,DU W,et al.Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation［J］.Neuro-oncology Advances,2022,4(1):vdac101.
［34］KARWACIAK I,SALKOWSKA A,KARAS K,et al.Targeting SIRT2 sensitizes melanoma cells to cisplatin via an EGFR-dependent mechanism［J］.International Journal of Molecular Sciences,2021,22(9):5034.
［35］BARBOSA MIA,BELINHA J,JORGE RMN,et al.Computationally modelling cell proliferation:A review［J］.International Journal for Numerical Methods in Biomedical Engineering,2023,39(7):e3715.
［36］LIN S,QIU L,LIANG K,et al.KAT2A/E2F1 promotes cell proliferation and migration via upregulating the expression of UBE2C in pan-cancer［J］.Genes,2022,13(10):1817.
［37］FERNANDES A,VIVEROS-CARRENO D,HOEGLOEGL J,et al.Human papillomavirus-independent cervical cancer［J］.International Gynecological Cancer Society,2022,32(1):1-7.
［38］陈静,王红静.SIRT2在宫颈癌组织中的表达及其临床意义［J］.四川大学学报(医学版),2019,50(05):701-707.
CHEN J,WANG HJ.Expression level of SIRT2 in cervical cancer tissue and its clinical significance［J］.Journal of Sichuan University(Medical Edition),2019,50(5):701-707.
［39］YANG L,FENG H,MA J,et al.SIRT2 expression exhibits potential to serve as a biomarker for disease surveillance and prognosis in the management of cervical cancer patients［J］.Medicine,2020,99(11):e18668.
［40］AJANI JA,D'AMICO TA,BENTREM DJ,et al.Gastric cancer,version 2.2022,NCCN clinical practice guidelines in oncology［J］.Journal of the National Comprehensive Cancer Network,2022,20(2):167-192.
［41］SUN L,ZHANG Y,YANG B,et al.Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer［J］.Nature Communications,2023,14(1):6523.
［42］WANG J,WU J,WANG L,et al.The LINC00152/miR-138 axis facilitates gastric cancer progression by mediating SIRT2［J］.Journal of Oncology,2021,2021:1173869.
［43］徐其银.miR-338-3p靶向SIRT2调控Wnt/β-catenin信号通路影响胃癌细胞迁移和侵袭的机制研究［D］.重庆:重庆医科大学,2021.
XU QY.Mechanism of miR-338-3p targeting SIRT2 to regulate Wnt/β-catenin signaling pathway affecting migration and invasion of gastric cancer cells［D］.Chongqing:Chongqing Medical University,2021.
［44］FAN X,WU Q.Decoding lung cancer at single-cell level［J］.Frontiers in Immunology,2022,13:883758.
［45］BANZ-JANSEB C,HELWEG LP,KLTSCHMIDT B.Endometrial cancer stem cells:where do we stand and where should we go［J］.International Journal of Molecular Sciences,2022,23(6):3412.
［46］ZHAO N,GUO Y,LIU P,et al.Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer［J］.Archives of Gynecology and Obstetrics,2022,305(3):693-701.
［47］BAIDOUN F,ELSHIWY K,ELKERAIE Y,et al.Colorectal cancer epidemiology:recent trends and impact on outcomes［J］.Current Drug Targets,2021,22(9):998-1009.
［48］MAO Y,WANG W,YANG J,et al.Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids［J］.Protein Cell,2024,15(4):285-304.
［49］WANG D,NI J,LI J,et al.Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylationv［J］.PLoS Pathogens,2023,19(2):e1011189.
［50］LI C,ZHOU Y,KIM JT,et al.Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells［J］.Biochimica et Biophysica Acta-Molecular Cell Research,2021,1868(4):118966.
［51］BAHADORAM S,DAVOODI M,HASSANZADEH S,et al.Renal cell carcinoma:an overview of the epidemiology,diagnosis,and treatment［J］.Giornale Italiano Di Nefrologia,2022,39(3):2022-vol3.
［52］LI Z,XU H,YU L,et al.Patient-derived renal cell carcinoma organoids for personalized cancer therapy［J］.Clinical and Translational Medicine,2022,12(7):e970.
［53］NI Y,YANG Z,AGBANA YL,et al.Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase［J］.Cancer Science,2021,112(10):4075-4086.
［54］YANG WY,CHEN W,SU HL,et al.Recent advances in the development of histone deacylase SIRT2 inhibitors［J］.RSC Advances,2020,10(61):37382-37390.